SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-339334
Filing Date
2021-11-24
Accepted
2021-11-24 06:50:58
Documents
12
Period of Report
2021-11-24
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d257439d8k.htm   iXBRL 8-K 22347
  Complete submission text file 0001193125-21-339334.txt   143731

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA kura-20211124.xsd EX-101.SCH 2904
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20211124_lab.xml EX-101.LAB 18139
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20211124_pre.xml EX-101.PRE 11416
5 EXTRACTED XBRL INSTANCE DOCUMENT d257439d8k_htm.xml XML 3359
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37620 | Film No.: 211441248
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences